Home / Resource Library / Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma

Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma

Results of a study examining blinatumomab for treatment of relapsed DLBCL.